Merck wins UK approval for lung disease drug acquired in $11 billion deal

UK's Medicines and Healthcare products Regulatory Agency said on Tuesday it had approved Merck's therapy to treat a rare lung condition, marking another win for the drugmaker's potential blockbuster.